Brave Asset Management Inc Geron Corp Transaction History

Brave Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 23, 2018	SELL	$1.76 - $6.38 $17,600 - $63,800	-10,000 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$1.81 - $5.98 $3,620 - $11,960	-2,000 Reduced 16.67%	10,000 $43,000
Q4 2017 Feb 09, 2018	SELL	$1.8 - $2.32 $1,620 - $2,088	-900 Reduced 6.98%	12,000 $22,000
Q3 2017 Nov 13, 2017	BUY	$1.99 - $2.65 $25,671 - $34,185	12,900	12,900 $28,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.09B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Brave Asset Management Inc with notifications on news.